HuGE Literature Finder
Records 1-6
|
Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.
Addiction (Abingdon, England) 2013 Dec 108 (12): 2202-11. David Sean P, Strong David R, Leventhal Adam M, Lancaster Molly A, McGeary John E, Munafò Marcus R, Bergen Andrew W, Swan Gary E, Benowitz Neal L, Tyndale Rachel F, Conti David V, Brown Richard A, Lerman Caryn, Niaura Raymo |
|
Genetic Analysis of Polymorphisms in Dopamine Receptor and Transporter Genes for Association with Smoking among Cancer Patients.
European addiction research 2012 Nov 19 (2): 2. Gordiev M, Engstrom PF, Khasanov R, Moroshek A, Sitdikov R, Dgavoronkov V, Schnoll RA |
|
Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.
Addiction biology 2008 Sep 13 (3-4): 435-9. Munafò Marcus R, Johnstone Elaine |
|
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
The pharmacogenomics journal 2008 Apr 8 (2): 122-8. David S P, Munafò M R, Murphy M F G, Proctor M, Walton R T, Johnstone E |
|
Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2007 Apr 56 (1): 17-23. Campa Daniele, Zienolddiny Shanbeh, Lind Helge, Ryberg David, Skaug Vidar, Canzian Federico, Haugen Aa |
|
Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples.
Journal of human genetics 2003 48 (12): 654-8. Yoshimura Kimio, Hanaoka Tomoyuki, Ohnami Shumpei, Ohnami Sumiko, Kohno Takashi, Liu Ying, Yoshida Teruhiko, Sakamoto Hiromi, Tsugane Shoichi |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 27, 2020
- Content source: